21 médecins Européens constituent le Conseil d’Administration d’ELI
Hervé Tilly, Président
Centre Henri Becquerel
Rouen – France
Marc André
LYSA
CHU UCL Namur, Site Godinne
Université Catholique de Louvain
Yvoir – Belgique
Igor Aurer
KroHem
University of Zagreb
Zagreb – Croatie
Pascal Bilbault
LYSARC – The
Lymphoma Academic Research Organisation
Centre Hospitalier Lyon Sud
Pierre-Bénite – France
www.lysarc.org
Dolores Caballero
Complejo Asistencial Universitario de Salamanca
Salamanque – Espagne
Martin Dreyling
Coordinator of the European MCL Network
Klinikum der Universität München – Medizinische Klinik III
Münich – Allemagne
www.european-mcl.net
Tarec El Galaly
Nordic Lymphoma Group
Aalborg University Hospital
Aalborg – Danemark
Massimo Federico
FIL
University of Modena and Reggio Emilia
Centro Oncologico Modenese
Modène – Italie
Andres Ferreri
FIL
San Raffaele Scientific Institute
Milan – Italie
Maria Gomes da Silva, Secrétaire
LYSA New University of Lisbon
Portuguese Institute of Oncology Lisbon
Lisbone – Portugal
Ingrid Glimelius
NLG
Karolinska Institutet – Uppsala University Hospital
Uppsala – Suède
Corinne Haioun, Trésorier
LYSA
Hôpitaux Universitaires Henri Mondor, AP-HP
Créteil – France
Marie-Josée Kersten
HOVON
AMC
Amsterdam – Pays-Bas
Eva Kimby
NLG
Karolinska Institute
Stockholm – Suède
Irina Kryachok
National Cancer Institute
Kiev – Ukraine
Sirpa Leppä
NLG
Dept Oncology Helsinki University Central Hospital Helsinki
Helsinki – Finlande
Armando Lopez Guillermo
GELTAMO
Hospital Clínic Barcelona
Barcelone – Espagne
Stefano Luminari
FIL
University of Modena and Reggio
Emilia
Modène – Italie
Andrew Pettitt
NCRI Lymphoma RG
University of Liverpool
Liverpool – Royaume-Uni
Marek Trněný
Charles University, General Hospital
Prague – Republique Tchèque
Jan Walewski
The Polish Lymphoma Research Group
Maria Sklodowska-Curie National Research Institute of Oncology
Varsovie – Pologne
Emanuele Zucca
IOSI – Oncology Institute of Southern Switzerland
Bellinzona – Suisse
www.ielsg.org
